Colombia

 

Veritas Intercontinental raises €5m as it off-shoots from ailing US business

Veritas Intercontinental, the spin-off of US genome sequencing group, Veritas Genetics, has raised €5m from existing investors to help finish building a new lab in Spain. CEO Javier de Echevarría tells HBI that the money will help to establish its independence from its former parent company which temporarily ceased US trading last year. 
October 15, 2020

Who might buy NMC’s hospital business?

NMC Health's administrators are making it clear that a wholesale selloff of the UAE's largest healthcare company is not viable. Could any of MENA's largest hospital operators - Mediclinic, VPS, and Aster DM - take over the hospital business? And who will be fighting for the rest? HBI speaks to an investor who knows NMC well to find out more.
June 18, 2020

KKR pulls out of Dentix deal

Global investment firm KKR has pulled out of a deal to take a majority stake in Spain’s biggest dental chain, Dentix, the company exclusively tells HBI. It is KKR's second high-profile decision not to invest in a large healthcare group this week.
February 13, 2020

Fresenius Helios expands further in LATAM

Spain's largest private hospital group Quironsalud, part of Fresenius Helios, has signed an agreement to acquire a substantial private hospital in Colombia as part of its continuing investment in the country. 
December 23, 2019

DomusVi acquires in Chile and targets Peru and Mexico

European nursing home operator DomusVi has acquired two facilities in Chile through its subsidiary Acalis as part of a rapid expansion strategy across the region. This is the group's second acquisition in Latin America, as growth has otherwise been focused on greenfield. We speak to the CEO of Acalis Latam about the group's regional strategy.
November 20, 2019

DomusVi appoints new CEO

Europe's third-largest nursing home group by revenue, DomusVi, has appointed a new CEO with no healthcare services management experience. He is the group's third CEO in the space of a year.
October 24, 2019

Interview: Julia Khalimova, Healthcare Quality and Patient Safety Specialist, International Finance Corporation (IFC)

A recent study in the Lancet showed that it was more dangerous to have access to poor quality health care than to have no access to health care. That is particularly true in Emerging Markets where quality varies dramatically. Julia Khalimova, Healthcare Quality and Patient Safety Specialist at IFC, the arm of the World Bank that invests in the private sectors of emerging markets, has been studying the field for ten years and IFC has recently launched a tool to enable operators to measure and improve. We talk to her about the problem. What progress has been made? And what is the best solution?
June 7, 2019
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us